Clinical Trials on Testicular Hypogonadism

Total 1199 results

Ferring Pharmaceuticals

Completed

Efficacy, Pharmacokinetics and Safety of Testosterone

Testicular Hypogonadism

United States
University of Southern California
National Cancer Institute (NCI)

Recruiting

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

Hypogonadism | Malignant Testicular Germ Cell Tumor

United States
Indiana University

Recruiting

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Coronary Artery Disease | Cisplatin Adverse Reaction | Lipid Disorder | Survivorship | Hypogonadism, Male | Testicular Cancer | Bone Marrow Transplant Complications | ASCVD

United States
Rigshospitalet, Denmark

Completed

Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors

Metabolic Syndrome | Hypogonadism | Cardio-vascular Disease

Denmark
Rigshospitalet, Denmark

Terminated

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Hypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, Male

Denmark
Shanghai Jiao Tong University School of Medicine

Unknown

Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism
Clarus Therapeutics, Inc.

Completed

Pharmacokinetic Study to Determine Time to Steady-state

Male Hypogonadism | Secondary Hypogonadism | Primary Hypogonadism

United States
Endo Pharmaceuticals

Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Hypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, Male

United States
Amneal Pharmaceuticals, LLC
Phase One Solutions, Inc.

Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Hypogonadotropic Hypogonadism | Primary Hypogonadism

United States
Endo Pharmaceuticals

Completed

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men (TU)

Hypogonadism | Secondary Hypogonadism | Primary Hypogonadism

United States
National Institute of Environmental Health Sciences...

Recruiting

Observation of Environment and Reproductive-Endocrine Effects

Precocious Puberty | Hypogonadism | Amenorrhea | Hypergonadism | Late Puberty

United States
Haukeland University Hospital
Karolinska University Hospital; Oslo University Hospital; University Hospital... and other collaborators

Recruiting

MicroRNA as Markers in Testicular Cancer

Seminoma | Testicular Germ Cell Cancer | Non-Seminoma Testicular Cancer | Stage I Testicular Cancer | Stage II Testicular Cancer | Stage III Testicular Cancer | Stage IV Testicular Cancer | Relapse Testicular Cancer

Norway, Sweden
Repros Therapeutics Inc.

Completed

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Obesity | Acquired Hypogonadotropic Hypogonadism

United States
Massachusetts General Hospital

Recruiting

Neuropeptides in Human Reproduction

Hypogonadotropic Hypogonadism

United States
Mereo BioPharma

Completed

A 6 Month Safety Extension Study of MBGS205

Hypogonadotropic Hypogonadism

United States
Organon and Co

Completed

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

Hypogonadotropic Hypogonadism | Hypogonadism
Texas Tech University Health Sciences Center

Completed

Effect of Intranasal Insulin on LH Concentrations in Man

Hypogonadotropic Hypogonadism

United States
Clarus Therapeutics, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaN...

Completed

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Male Hypogonadism

United States, Germany
Clarus Therapeutics, Inc.
inVentiv Health Clinical

Completed

Safety and Efficacy Trial of Testosterone Undecanoate

Male Hypogonadism

United States
Lipocine Inc.
PPD; Syneos Health

Completed

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism (SOAR)

Male Hypogonadism
Fudan University

Recruiting

An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients (LPS-IHH)

Idiopathic Hypogonadotropic Hypogonadism | Luteal Phase Support | Luteal Phase Deficiency

China
Huashan Hospital

Recruiting

Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH

Hypogonadotropic Hypogonadism

China
Stephanie B. Seminara, MD

Recruiting

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United States
Stephanie B. Seminara, MD

Enrolling by invitation

Opioid Antagonism in Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United States
Azienda Ospedaliero-Universitaria di Modena

Recruiting

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men (RHYTHM)

Acquired Hypogonadotropic Hypogonadism

Italy
Marius Pharmaceuticals
Syneos Health

Completed

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Lipocine Inc.

Completed

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). (DV)

Hypogonadism, Male
Lund University

Completed

Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males

Hypogonadism, Male
Ferring Pharmaceuticals

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Adult Male Hypogonadism

United States
GlaxoSmithKline

Completed

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

Hypogonadism | Hypogonadism, Male

United States
Gulhane School of Medicine

Completed

The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
Gulhane School of Medicine

Completed

Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
Gulhane School of Medicine

Completed

Effects of Medications in Patients With Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
University of Washington
Washington State University

Not yet recruiting

Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 (OralT12)

Hypogonadism, Male
University of Florida
Acerus Pharmaceutical

Recruiting

Natesto Spermatogenesis Reboot

Hypogonadism, Male

United States
The Royal Wolverhampton Hospitals NHS Trust

Active, not recruiting

Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses (Sal T)

Hypogonadism, Male

United Kingdom
University of Miami
Acerus Pharmaceuticals Corporation

Completed

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

Hypogonadism, Male

United States
Marius Pharmaceuticals
Syneos Health

Completed

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Martin Blomberg Jensen

Completed

Calciotropic Effects After hCG Stimulation Test

Hypogonadism, Male

Denmark
Clarus Therapeutics, Inc.
Celerion; Syneos Health; ARUP Laboratories

Completed

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Hypogonadism, Male

United States
Acerus Pharmaceuticals Corporation

Completed

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Male Hypogonadism

United States
Ferring Pharmaceuticals

Completed

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

Adult Male Hypogonadism

United States, Canada
Gulhane School of Medicine

Completed

Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism
GlaxoSmithKline

Completed

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Hypogonadism | Hypogonadism, Male

United States
Lo.Li.Pharma s.r.l

Completed

D-chiroinositol Administration in Hypogonadal Males

Sexual Dysfunction | Male Hypogonadism

Italy
Texas Tech University Health Sciences Center

Withdrawn

Autonomic Manifestations of Testosterone Deficiency in Men

Male Hypogonadism | Autonomic Neuropathy

United States
Massachusetts General Hospital

Terminated

Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders

Hypothalamic Amenorrhea | Idiopathic Hypogonadotropic Hypogonadism

United States
Stephanie B. Seminara, MD

Recruiting

Kisspeptin Administration Subcutaneously to Patients With IHH

Hypogonadotropic Hypogonadism

United States
Organon and Co

Completed

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)

Hypogonadotropic Hypogonadism

Brazil, Denmark, Italy, Mexico, Russian Federation, South Africa
Clarus Therapeutics, Inc.

Completed

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

Male Hypogonadism

United States, Germany

Clinical Trials on Testicular Hypogonadism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations